NVO’s Ryzodeg hits primary endpoint in phase-3 trial: http://in.reuters.com/article/2014/09/18/us-novo-nordisk-study-idINKBN0HD10M20140918 Ryzodeg is a combination of Treshiba and NovoRapid in a single pen.